Share Email Print
cover

Proceedings Paper

Two-photon excitation photodynamic therapy with Photofrin
Author(s): Aliaksandr Karotki; Mamta Khurana; James R. Lepock; Brian C. Wilson
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Photodynamic therapy (PDT) based on simultaneous two-photon (2-γ) excitation has a potential advantage of highly targeted treatment by means of nonlinear localized photosensitizer excitation. One of the possible applications of 2-γ PDT is a treatment of exodus age-related macular degeneration where highly targeted excitation of photosensitizer in neovasculature is vital for reducing collateral damage to healthy surrounding tissue. To investigate effect of 2-γ PDT Photofrin was used as an archetypal photosensitizer. First, 2-γ absorption properties of Photofrin in the 750 - 900 nm excitation wavelength range were investigated. It was shown that above 800 nm 2-γ interaction was dominant mode of excitation. The 2-γ cross section of Photofrin was rather small and varied between 5 and 10 GM (1 GM = 10-50 cm4s/photon) in this wavelength range. Next, endothelial cells treated with Photofrin were used to model initial effect of 2-γ PDT on neovasculature. Ultrashort laser pulses provided by mode-locked Ti:sapphire laser (pulse duration at the sample 300 fs, repetition rate 90 MHz, mean laser power 10 mW, excitation wavelength 850 nm) were used for the excitation of the photosensitizer. Before 2-γ excitation of the Photofrin cells formed a single continuous sheet at the bottom of the well. The tightly focused laser light was scanned repeatedly over the cell layer. After irradiation the cell layer of the control cells stayed intact while cells treated with photofrin became clearly disrupted. The light doses required were high (6300 Jcm(-2) for ~ 50% killing), but 2-γ cytotoxicity was unequivocally demonstrated.

Paper Details

Date Published: 14 October 2005
PDF: 8 pages
Proc. SPIE 5969, Photonic Applications in Biosensing and Imaging, 596915 (14 October 2005); doi: 10.1117/12.628132
Show Author Affiliations
Aliaksandr Karotki, Ontario Cancer Institute, Univ. of Toronto (Canada)
Mamta Khurana, Ontario Cancer Institute, Univ. of Toronto (Canada)
James R. Lepock, Ontario Cancer Institute, Univ. of Toronto (Canada)
Brian C. Wilson, Ontario Cancer Institute, Univ. of Toronto (Canada)


Published in SPIE Proceedings Vol. 5969:
Photonic Applications in Biosensing and Imaging
Brian C. Wilson; Robert A. Weersink; Richard I. Hornsey; Warren C. W. Chan; Kui Yu; Ulrich J. Krull, Editor(s)

© SPIE. Terms of Use
Back to Top